A skewing of Trp metabolism toward the KP occurs in AD, where increased activity of indoleamine 2,3-dioxygenase (IDO1) converts Trp to quinolinic acid, a recognized NMDA receptor agonist and oxidant, thereby increasing tau phosphorylation and neuroinflammation [48, 76]. This evidence concerns the gene MAPT and Alzheimer disease.